|
LOC647979 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.82569515061459E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.18770043484085E-10 |
| Normal-vs-Stage2 |
5.82869999999902E-05 |
| Normal-vs-Stage3 |
6.44300002239362E-09 |
| Normal-vs-Stage4 |
3.77209999902206E-08 |
| Stage1-vs-Stage2 |
8.581600E-01 |
| Stage1-vs-Stage3 |
7.637800E-01 |
| Stage1-vs-Stage4 |
2.815400E-01 |
| Stage2-vs-Stage3 |
7.120600E-01 |
| Stage2-vs-Stage4 |
3.387000E-01 |
| Stage3-vs-Stage4 |
3.997600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.99139626800138E-11 |
| Normal-vs-AfricanAmerican |
9.361300E-03 |
| Normal-vs-Asian |
7.10989999985756E-07 |
| Caucasian-vs-AfricanAmerican |
1.594640E-01 |
| Caucasian-vs-Asian |
7.333800E-01 |
| AfricanAmerican-vs-Asian |
1.324020E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.18659979012159E-10 |
| Normal-vs-Female |
4.09259959255337E-10 |
| Male-vs-Female |
2.908800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.81029999563643E-08 |
| Normal-vs-Age(41-60Yrs) |
1.04169994852299E-09 |
| Normal-vs-Age(61-80Yrs) |
2.0374999465389E-09 |
| Normal-vs-Age(81-100Yrs) |
8.623600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.065000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.288400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.048200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.929200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.558800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.394000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.139600E-02 |
| Classical-VS-Follicular |
6.41209999999726E-05 |
| Classical-VS-Other |
5.587700E-02 |
| Classical-VS-Normal |
7.07470000360644E-08 |
| Tall-VS-Follicular |
3.843000E-01 |
| Tall-VS-Other |
2.640000E-01 |
| Tall-VS-Normal |
6.32150000012821E-07 |
| Follicular-VS-Other |
5.493000E-01 |
| Follicular-VS-Normal |
6.08119998801726E-10 |
| Other-VS-Normal |
1.198290E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.30310240165477E-11 |
| Normal-vs-N1 |
6.39560000514905E-08 |
| N0-vs-N1 |
4.729200E-01 |
|
|
